Issue : The Pharmaceutical Journal, March 2020, Vol 304, No 7935
Sort by: Newest first Oldest first A-Z Z-A
-
We must not forget transgender patients’ physiology if we are to prescribe safely Subscription
Pharmacists should always be respectful of patients’ identity wishes, but biological differences between the sexes mean that conflating sex and gender could have serious implications for prescribing.
-
Scottish Pharmacy Board meeting: 22 January 2020
At the latest Royal Pharmaceutical Society Scottish Pharmacy Board meeting, discussions revolved around pharmacotherapy, science and research, and public affairs in Scotland.
-
English Pharmacy Board meeting: 30 January 2020
At the latest Royal Pharmaceutical Society English Pharmacy Board meeting, discussions revolved around plans for science and research, and a digital edition of Medicines, Ethics and Practice.
-
Welsh Pharmacy Board meeting: 5 February 2020
At the latest Royal Pharmaceutical Society Welsh Pharmacy Board meeting, discussions revolved around Brexit, medicines shortages and public affairs in Wales.
-
Case-based learning: management of polycystic ovary syndrome Subscription
As the most common incurable hormonal condition affecting women of reproductive age, polycystic ovary syndrome can lead to infertility, anxiety and cardiovascular disease if it is not managed appropriately.
-
How employers can help support staff with disabilities Subscription
Employers have a duty of care to support the health, safety and wellbeing of all employees, including those with disabilities.
-
Considerations for the inpatient management of Parkinson’s disease Subscription
Recognising and managing certain complications of Parkinson’s disease can help improve care and reduce the risk of admission for people living with the condition.
-
Going against type: the new class of cancer therapies targeting mutations rather than tissues Subscription
‘Tumour agnostic’ drugs offer a more effective and tolerable therapy for a wide range of people with cancer, so why has the NHS rejected its first one?
-
Funding to be made available for home deliveries, says NHS England and NHS Improvement
The cost of delivering medicines to vulnerable patients who are self-isolating or have COVID-19 will be reimbursed, Simon Stevens, the chief executive of NHS England has said.
-
Medicines regulator and NICE to review evidence of impact of NSAIDs on COVID-19
The Committee of Human Medicines — an advisory body of the Medicines and Healthcare products Regulatory Agency — and the National Institute for Health and Care Excellence are to review the evidence on the impact of non-steroidal anti-inflammatory drugs on the severity of COVID-19 infection.
-
Pharmacists are on the front line of COVID-19, but they need help too
An urgent package of funding and support is required to enable pharmacists to support vulnerable people during the COVID-19 pandemic.
-
Effective detection and management of hypertension through community pharmacy in England Subscription
Management of hypertension does not routinely occur in English pharmacies, despite community pharmacy being an ideal place for screening to take place. By examining and learning from the evidence, pharmacies in England can help patients maintain ideal blood pressure levels and improve health outcomes.
-
National pharmacy board elections 2020
Members are advised to take note of the deadlines for nominations and any subsequent elections to the Society’s national pharmacy boards.
-
Acute coronary syndrome: risk factors, diagnosis and treatment Subscription
This overview describes the different management options for acute coronary syndrome and how pharmacists can support patients with the condition.
-
‘Significant’ fall in referrals to GPs since introduction of pharmacy consultation service Subscription
NHS 111 has seen a 6% drop in referrals to GP surgeries since the community pharmacist consultation service was launched in October 2019, according to Anne Joshua, head of pharmacy integration at NHS England and NHS Improvement.
-
The race to stop COVID-19
As a new strain of coronavirus threatens public health systems across the globe, researchers are racing to develop a vaccine.
-
Young people who vape are almost five times more likely to start smoking, research suggests Subscription
Young people who have tried e-cigarettes are nearly five times more likely to go on to try smoking, a review of the evidence suggests. However, it remains unclear whether or not e-cigarettes act as a ‘gateway’ to smoking.
-
Regulator may temporarily re-register 6,000 pharmacy staff to cope with a COVID-19 emergency
The General Pharmaceutical Council has drawn up plans to temporarily re-register pharmacists and pharmacy technicians if the government launches a state of emergency in relation to COVID-19.
-
Nikki Kanani: 'Shortages of the right pharmacists in some areas has been an issue' Subscription
The director of primary care at NHS England speaks about growing up in a pharmacy, her hopes for the sector and how to protect pharmacists from burnout.
-
Tribute: Martin Leonard Ibbitt
It was with great sadness that I heard of the death of Martin Ibbitt after a short illness.
Show 10 per page20 per page50 per page
